INS and type 2 diabetes mellitus: A prospective study showed that 56.1% of LADA patients progressed to require insulin therapy during a 7-year follow-up period, compared with 20.9% of T2D patients, and that high GADA titer increased the risk of insulin requirement in LADA patients (59).